Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 312

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

1,2,3‐Triazole hybrids as anticancer agents: A review

Alam, Mohammad Mahboob·2022·Archiv der Pharmazie

Abstract

Despite the advancements in the development of anticancer agents, more effective and safer anticancer drugs still need to be developed as the current agents cause unwanted side effects and many patients have become drug resistant. 1,2,3‐Triazoles, due to their remarkable biological potential, have received considerable attention in drug discovery for the development of anticancer agents. The present review article presents an overview of the recent advances in 1,2,3‐triazole hybrids with anticancer potential over the last 2 years, their chemical structures, structure–activity relationships, and mechanisms of action, as well as insights into the docking studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ardp.202100158

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Metadata

Authors
Alam, M. M.
Venue
Archiv der Pharmazie
Publisher
Wiley
Published
2021-09-24
Volume
355
Issue
1
Pages
e2100158-e2100158
ISSN
  • 0365-6233 (ISSN-L)
  • 1521-4184
OpenAlex
W3199081935
Cited by
312
References
56
FWCI
18.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 1,2,3‐Triazole hybrids as anticancer agents: A review. https://app.cochat.ai/papers/10.1002/ardp.202100158
The paper
Alam, M. M. (2022). 1,2,3‐Triazole hybrids as anticancer agents: A review. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202100158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.